Immunogenicity and Reactogenicity of a New Measles, Mumps and Rubella Vaccine When Administered as a Second Dose at 12 y of Age

Author： Gothefors Leif   Bergström Erik   Bäckman Margareta  

Publisher： Informa Healthcare

ISSN： 0036-5548

Source： Scandinavian Journal of Infectious Diseases, Vol.33, Iss.7, 2001-07, pp. : 545-549

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunogenicity and Reactogenicity of a Single Dose of Live Attenuated Varicella Vaccine and a Booster Dose of Measles-Mumps-Rubella Vaccine Given Concomitantly at 12 years of Age

By Parment Per Arne   Svahn Anita   Rudén Ulla   Bråkenhielm Görel   Storsaeter Jann   Åkesson Lena   Linde Annika  

Scandinavian Journal of Infectious Diseases, Vol. 35, Iss. 10, 2003-10 ,pp. : 736-742

Informa Healthcare

Access to resources Recommend Favorite

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 4, 2015-08 ,pp. : 597-602

John Wiley & Sons Inc

Access to resources Recommend Favorite

By  

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol. 51, Iss. 8, 2015-08 ,pp. : 838-838

John Wiley & Sons Inc

Access to resources Recommend Favorite

Suspected measles–mumps–rubella vaccine-related encephalitis: Two cases

By Shuper Avinoam  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 1, 2011-01 ,pp. : 75-78

Informa Healthcare

Access to resources Recommend Favorite

Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 6, 2015-06 ,pp. : 667-671

John Wiley & Sons Inc

Access to resources Recommend Favorite